Section I
431 – 440 of 5032
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
- Contribution to journal › Article
-
Mark
Evaluating patient reported outcomes and experiences in a novel proton beam clinic – challenges, activities, and outcomes of the ProtonCare project
- Contribution to journal › Article
-
Mark
Proteogenomics decodes the evolution of human ipsilateral breast cancer
- Contribution to journal › Article
-
Mark
Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer : Data from the Swedish TP53 Study
- Contribution to journal › Article
-
Mark
Analysis of Extracellular Vesicle-Associated Proteoglycans
- Contribution to journal › Article
-
Mark
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
- Contribution to journal › Article
-
Mark
Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
- Contribution to journal › Article
-
Mark
The role of primary care in the cancer care continuum : a qualitative study of cancer survivors’ experiences
- Contribution to journal › Article
-
Mark
Cholesterol metabolism in breast cancer: Prognostic factors and optimizing treatment
(2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
UROSCAN and UROSCANSEQ : a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice–from biobank to RNA-sequencing in real time
- Contribution to journal › Article
